Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography. (Q53304428)

13 May 2018

title

Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography. (English)

1 reference

13 May 2018

1 reference

1

Heiss WD

1 reference

13 May 2018

Karl Herholz

7

object named as

Herholz K

1 reference

13 May 2018

Ziffling P

4

object named as

Ziffling P

1 reference

13 May 2018

author name string

Hebold I

2

1 reference

13 May 2018

Klinkhammer P

3

1 reference

13 May 2018

Szelies B

5

1 reference

13 May 2018

Pawlik G

6

1 reference

13 May 2018

publication date

1 August 1988

1 reference

13 May 2018

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

13 May 2018

volume

8

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

page(s)

613-617

1 reference

13 May 2018

describes a project that uses

positron emission tomography

1 reference

The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Physostigmine: Improvement of Long-Term Memory Processes in Normal Humans

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Positron Emission Tomography in the Study of Aging and Senile Dementia

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

1 reference

7 January 2021

Alzheimer's disease: focal cortical changes shown by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Pathological and positron emission tomographic correlations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Cerebral blood flow in dementia

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Computer assisted mapping in quantitative analysis of cerebral positron emission tomograms.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Cholinergic approaches to the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

[Cerebral glucose metabolism in presenile dementia of the Alzheimer type--follow-up of therapy with muscarinergic choline agonists]

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Estimation of local cerebral glucose utilization by positron emission tomography of [18F]2-fluoro-2-deoxy-D-glucose: a critical appraisal of optimization procedures

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.104

7 January 2021

Identifiers

DOI

10.1038/JCBFM.1988.104

1 reference

13 May 2018

PubMed ID

3260597

1 reference

13 May 2018